Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
21.57
+0.68 (3.26%)
Jul 23, 2026, 4:00 PM EDT - Market closed

KMTS Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2021
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '21
Net Income
-131.61-113.81-94.12--34.1
Depreciation & Amortization
8.717.9711.56-0.42
Stock-Based Compensation
33.6424.271.49-1.86
Other Adjustments
5.7810.174.95-1.94
Change in Receivables
-9.06-8.78-2.5--
Changes in Inventories
-0.46-3.44-1.18--
Changes in Accounts Payable
4.32.847.34--0.13
Changes in Accrued Expenses
8.24.620.37-2.11
Changes in Other Operating Activities
-1.21-1.44-0.15--2
Operating Cash Flow
-81.7-77.61-72.24-69.64-29.9
Capital Expenditures
-34.89-22.94-12.23--0.34
Sale of Property, Plant & Equipment
----0
Purchases of Investments
-168.04----
Other Investing Activities
-0.34-0.37-0--
Investing Cash Flow
-203.28-23.31-12.23-15.46-0.33
Long-Term Debt Issued
--45-20
Long-Term Debt Repaid
---39.12--
Net Long-Term Debt Issued (Repaid)
--5.88-20
Issuance of Common Stock
149.88235.26--30.33
Net Common Stock Issued (Repurchased)
149.88235.26--30.33
Issuance of Preferred Stock
-103.475--
Net Preferred Stock Issued (Repurchased)
-103.475--
Other Financing Activities
-2.79-8.4-3.15--1.52
Financing Cash Flow
147.1330.2677.7396.1148.82
Net Cash Flow
-137.89229.35-6.741118.59
Free Cash Flow
-116.6-100.54-84.46-69.64-30.23
FCF Margin
-122.57%-168.09%-303.66%-912.74%-
Free Cash Flow Per Share
-2.15-4.09-4.25-658192.00-
Levered Free Cash Flow
-146.96-138.53-89.24-86.74-14.04
Unlevered Free Cash Flow
-150.39-118.9-79.36-80.44-32.82
SEC Filings: 10-K · 10-Q